Target intelligence / Profile preview

Double homeobox 4 like 19 (DUX4L19)

Target: DUX4L19
Molecular classification: Other, Pseudogene

Overview

Double homeobox 4 like 19 (DUX4L19) is annotated as a pseudogene in human genomic resources and does not encode a functional protein. It is related to the DUX4 gene, which encodes a double homeobox transcription factor important in early embryonic gene regulation and is implicated in diseases such as facioscapulohumeral muscular dystrophy (FSHD) and certain leukemias[1][3][5]. However, there is no evidence that DUX4L19 produces a functional protein, participates in known biological processes, or serves as a therapeutic target. Most references to DUX4L19 in databases indicate its status as a pseudogene, and there are no known drugs targeting this entity, nor is it considered clinically meaningful as a biomarker or therapeutic concern[2][4].

Other names: DUXY4DUX4L19

Beyond the preview

Go deeper on Double homeobox 4 like 19 (DUX4L19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double homeobox 4 like 19 (DUX4L19).

Explore the full profile